Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Common Equity (2016 - 2024)

Avricore Health has reported Common Equity over the past 11 years, most recently at $1.4 million for Q4 2024.

  • Quarterly Common Equity fell 4.55% to $1.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2024, down 4.55% year-over-year, with the annual reading at $1.4 million for FY2024, 3.48% down from the prior year.
  • Common Equity was $1.4 million for Q4 2024 at Avricore Health, down from $1.5 million in the prior quarter.
  • Over five years, Common Equity peaked at $1.7 million in Q4 2021 and troughed at -$685080.5 in Q3 2020.
  • The 5-year median for Common Equity is $1.3 million (2023), against an average of $564094.1.
  • Year-over-year, Common Equity plummeted 382.04% in 2020 and then skyrocketed 413.82% in 2021.
  • A 5-year view of Common Equity shows it stood at -$555379.0 in 2020, then surged by 413.82% to $1.7 million in 2021, then dropped by 16.98% to $1.4 million in 2022, then increased by 1.98% to $1.5 million in 2023, then decreased by 4.55% to $1.4 million in 2024.
  • Per Business Quant, the three most recent readings for AVCRF's Common Equity are $1.4 million (Q4 2024), $1.5 million (Q4 2023), and $1.3 million (Q2 2023).